{
    "score": [
        1.0
    ],
    "extracted": [
        3
    ],
    "abstract": [
        "geoffrey wolf sells 34,938 shares of opiant pharmaceuticals inc stock ."
    ],
    "id": "385867.train",
    "article": [
        "opiant pharmaceuticals inc major shareholder geoffrey wolf sold 34,938 shares of the stock in a transaction dated monday , december 18th . the shares were sold at an average price of $ 22.67 , for a total transaction of $ 792,044.46 . the sale was disclosed in a document filed with the securities & exchange commission , which is available at the sec website . large shareholders that own more than 10 % of a company 's shares are required to disclose their sales and purchases with the sec . geoffrey wolf also recently made the following trade : on friday , december 8th , geoffrey wolf sold 2,570 shares of opiant pharmaceuticals stock . ",
        "the shares were sold at an average price of $ 30.40 , for a total transaction of $ 78,128.00 . shares of opiant pharmaceuticals inc opened at $ 24.95 on friday . opiant pharmaceuticals inc has a 12-month low of $ 5.00 and a 12-month high of $ 51.90 . the stock has a market cap of $ 49.01 , a pe ratio of 59.40 and a beta of -2.33 . opiant pharmaceuticals last released its quarterly earnings data on monday , december 4th . the technology company reported earnings per share for the quarter , missing the thomson reuters ' consensus estimate of by . ",
        "opiant pharmaceuticals had a return on equity of 42.44 % and a net margin of 8.93 % . the firm had revenue of $ 0.02 million for the quarter . research analysts forecast that opiant pharmaceuticals inc will post -6.63 eps for the current fiscal year . a number of equities research analysts have recently commented on opnt shares . valuengine upgraded shares of opiant pharmaceuticals from a `` buy '' rating to a `` strong-buy '' rating in a research report on tuesday , september 12th . thestreet upgraded shares of opiant pharmaceuticals from a `` c + '' rating to a `` b '' rating in a research report on monday , october 16th . ",
        "warning : `` geoffrey wolf sells 34,938 shares of opiant pharmaceuticals inc stock '' was published by watch list news and is owned by of watch list news . if you are accessing this news story on another website , it was copied illegally and republished in violation of u. s. and international trademark and copyright law . the correct version of this news story can be accessed at pharmaceuticals company profileopiant pharmaceuticals , inc , formerly lightlake therapeutics , inc , is a specialty pharmaceutical company . the company develops pharmacological treatments for substance use , addictive and eating disorders . ",
        "the company has developed narcan nasal spray , a treatment to reverse opioid overdoses , which was conceived , licensed , developed and approved by the united states food and drug administration .   "
    ]
}